Is 2219.HK overvalued or undervalued?

2219.HK currently has a P/E ratio of 8.47. Relative to the sector average of 26.80, this suggests the stock may be undervalued. A higher P/E than peers means investors are paying more for each unit of earnings, often because they expect faster future growth. However, if that growth does not materialize, the stock can appear overvalued. A lower P/E may indicate weaker growth expectations or higher risk, but it can also signal a potential valuation discount.

How can I buy Chaoju Eye Care Holdings Limited stock?

Chaoju Eye Care Holdings Limited trades on HKSE. Investors in Latin America can buy it through international and regional brokerage and investment platforms. You simply need a valid government ID or passport to get started.

Can I buy fractional shares of 2219.HK?

Yes. Through fractional investing, you can invest exactly the amount you want, starting with as little as $1 or $5 USD (depending on what investment platform you use), and own a proportional piece of the company.

Does buying 2219.HK protect my money against local inflation?

Many investors in Latin America buy international stocks like 2219.HK to protect their purchasing power. Because 2219.HK is priced in foreign currency, your investment is tied to a hard currency. If your local currency devalues against the foreign currency, usually USD or Euro, the underlying value of your stock portfolio remains protected from local inflation.

Do I need a foreign bank account or a Visa to buy 2219.HK shares?

No. A common misconception is that you need a foreign bank account or a foreign visa to invest in international stocks. Today, modern investment platforms allow you to fund your account using local bank transfers or local payment methods right from your home country.

Is 2219.HK a suitable investment for my portfolio?

There is no universal answer, since fit depends on your situation, not just the stock. Think about three things: how well 2219.HK diversifies what you already own, whether you can stomach its price swings given your risk tolerance, and how long you plan to stay invested. As a rule, a single stock works best as one piece of a broader asset allocation and with a multi-year time horizon. This is general information, not personalized financial advice.

All stocks2219.HK

Chaoju Eye Care Holdings Limited

HK$2.39+HK$0.00+0.00%

HKSE / HKD

Market cap

HK$1.7B

P/E

8.5

EPS (TTM)

HK$0.03

Dividend yield

10.16%

Beta

0.57

1Y return

-12.18%

Deposit US$200 and get US$50 for freeT&C apply. Your capital is at risk.Invest with

Compare, tap a companyup to 2 at once

Deposit US$200 and get US$50 for freeT&C apply. Your capital is at risk.Invest with

Financials

The numbers behind the company

Revenue vs net income

RevenueNet income

$157M2021

$143M2022

$193M2023

$192M2024

$194M2025

Financial health

Gross margin

Operating margin

ROE

ROA

Debt to equity0.11Low
Current ratio3.87
Cash ratio0.55
Net margin12.0%
Free cash flow—

Valuation

Is it expensive right now

P/E vs the market

scale 0–50

0153050

2219.HK8.5
Healthcare sector median26.8
S&P 50022.0

Trades about 68% below its sector, cheaper than its peers on earnings.

Ratios

PEG0.08
Price to book0.61
EPS (TTM)HK$0.03
Payout ratio9,085%
FCF yield6.54%

Range & risk

HK$2.20HK$3.14

Trading in the lower third of its 52-week band

Beta0.57

Profile

What Chaoju Eye Care Holdings Limited actually does

Chaoju Eye Care Holdings Limited owns and operates a network of ophthalmic hospitals and optical centers in China. Its consumer ophthalmic services include treatments and prevention for various ophthalmic disorders, such as refractive and presbyopia correction, myopia prevention and control, dry eye syndrome, and oculoplastic, as well as optical products and services. The company also provides treatment for eye diseases, including cataract, glaucoma, squint, ocular fundus diseases, ocular surface diseases, orbital diseases, and pediatric eye diseases. In addition, it offers Amblyopia recovery services; and sells eyewear, equipment, and optical products. Chaoju Eye Care Holdings Limited was founded in 1988 and is headquartered in Beijing, China.

CEO

Bo Zhou Zhang

Employees

2,619

Headquarters

Beijing, BE

Founded

2021-07-07

Company website

If you had invested a decade ago

Loading the full price history…

Run your own numbers

Past performance is not a forecast.

ETFs

Own it inside an ETF instead

Vanguard S&P 500

Vanguard Total Stock Market

Vanguard Total World Stock

Invesco QQQ

SPDR S&P 500

iShares Russell 2000

Community sentiment

Bullish—

Distribution

Bearish0%
Neutral0%
Bullish0%

Track it without buyingTrack it

no account needed

Save 2219.HK and get told when something moves.

Get updates

A clear, direct weekly summary.

Keep looking

Q&A

Questions people ask

2219.HK has a beta of 0.57, which indicates how sensitive it has historically been to movements in its broader market. A beta below 1 indicates lower relative volatility than the market. Beta is based on historical data and does not predict future performance.

Chaoju Eye Care Holdings Limited